SillaJen, Inc.
Develops oncolytic viruses and immunotherapeutics to destroy difficult-to-treat cancer cells.
215600 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 중구 청계천로 106 3층(수표동, 크리스탈스퀘어), 중구
- Website:
- https://www.sillajen.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
SillaJen, Inc. is a biotechnology company focused on the research, development, and commercialization of oncolytic immunotherapeutics for cancer treatment. The company engineers oncolytic viruses designed to selectively replicate in and destroy cancer cells while stimulating a systemic anti-tumor immune response. Its main pipeline candidate is Pexa-Vec (JX-594), an oncolytic and immunotherapeutic vaccinia virus that has been investigated for the treatment of various solid tumors. SillaJen is dedicated to developing innovative therapeutic options for patients with difficult-to-treat cancers through its proprietary viral engineering platforms.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for SillaJen, Inc. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
Automate Your Workflow. Get a real-time feed of all SillaJen, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for SillaJen, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
